Pharma-Bio Serv (OTCMKTS:PBSV) Announces Earnings Results, Misses Expectations By $0.04 EPS

Pharma-Bio Serv (OTCMKTS:PBSV) posted its quarterly earnings results on Monday. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.03 by ($0.04), Yahoo Finance reports. Pharma-Bio Serv had a negative net margin of 0.05% and a negative return on equity of 0.04%. The business had revenue of $2.42 million during the quarter, compared to analysts’ expectations of $3.50 million.

Pharma-Bio Serv Stock Performance

OTCMKTS PBSV opened at $0.63 on Wednesday. Pharma-Bio Serv has a fifty-two week low of $0.52 and a fifty-two week high of $1.09. The business has a 50 day moving average price of $0.62 and a two-hundred day moving average price of $0.69.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.